RNA Expression Profiles May Guide Future Targeted Therapy in Urothelial Cancer
Understanding subtype-specific profiles of urothelial carcinoma could help tailor targeted therapies and identify biomarkers for treatment optimization. At the ESMO 2025 congress, a German study gave new insights into RNA expression of molecular targets across tumor types of urothelial carcinoma.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
